This issue of the ECDC Communicable Disease Threats Report (CDTR) the period 21-27 January 2024 and includes updates on SARS-CoV-2, influenza, cholera, chikungunya, dengue and zika.
The aim of this survey was to review the expertise, capabilities and capacities for detection and characterisation of avian and other zoonotic influenza viruses in national influenza reference laboratories in the European Union/European Economic Area (EU/EEA), in members of the European Reference Laboratories for influenza (ERLINet), and in EU Enlargement policy countries.
This report presents the results of the 11th round of the external quality assessment (EQA-11) scheme for typing of Shiga toxin-producing Escherichia coli (STEC).
This document aims to provide guidance for public health and laboratory experts in identifying human infections with animal influenza viruses as early as possible to provide early warning and inform risk assessments and public health measures.
This report presents the results of the European External Influenza Quality Assessment Programme 2020 for influenza reference laboratories in the WHO European Region, designed and prepared by the contractor and funded by ECDC and WHO Regional Office for Europe.
This report presents the results of the 10th round of the external quality assessment (EQA-10) scheme for typing of Shiga toxin-producing Escherichia coli (STEC).
Rapid risk/outbreaks assessment aim at supporting the countries and the European Commission in their preparedness and response to a public health threat. They provide a timely summary and risk assessment of a public health threat for EU/EEA countries related to a specific event. They also include potential options for response. As outbreaks or public health events develop, ECDC may issue updated risk assessments.
This report presents the results of the ninth round of the external quality assessment (EQA-9) scheme for typing of Shiga toxin-producing Escherichia coli (STEC).